A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1.
Health Technol Assess
; 10(20): iii-iv, ix-113, 2006 Jun.
Article
em En
| MEDLINE
| ID: mdl-16729919
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Doença de Fabry
/
Mucopolissacaridoses
/
Alfa-Galactosidase
/
Iduronidase
Tipo de estudo:
Health_economic_evaluation
/
Health_technology_assessment
/
Prognostic_studies
/
Systematic_reviews
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
País como assunto:
Europa
Idioma:
En
Ano de publicação:
2006
Tipo de documento:
Article